PTPN11 and hepatocellular carcinoma: Because our earlier results indicating a loss of SHP2 in HCC tissues relative to HBV-positive paired background tissues were not obtained from a random cohort, we performed an additional immunohistochemical analysis of SHP2 expression in 162 tissues from patients with HBV-associated HCC (Supplementary Table 1).